The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class ...
MedPage Today on MSN
FDA, CMS to launch speedy coverage pathway for breakthrough medical devices
Eligible devices could be covered by Medicare as soon as 2 months after market authorizati ...
The US Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have proposed a parallel ...
The US Food and Drug Administration (FDA) saw more new recall events for class I medical devices in 2025 than it has in ...
Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and manifolds.
FDA issued a warning to drug-device combination manufacturers about nitrosamine impurities that could increase the risk of ...
In November, the Food and Drug Administration (FDA) held a Digital Health Advisory Committee meeting where it considered treating artificial intelligence mental health chatbots as medical devices. As ...
RAPID could enable Medicare coverage and payment as soon as two months after FDA approval, compared to a year or more with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results